Tools
Upgrade to Pro 🌟

Upgrade for Pro stock ideas, Al signals, and more search.

Learn More

HRMY

Harmony Biosciences Holdings, Inc. · NASDAQ

Performance

-4.2%

1W

-4.95%

1M

+2.01%

3M

+4.69%

6M

+2.32%

YTD

+32.57%

1Y

Profile

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Technical Analysis of HRMY 2024-11-04

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 23 indicating strong bearish momentum, the Oscillators Score at 46 suggesting a neutral stance, and the Technical Score at 35 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend leans towards w...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of HRMY

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.